NETs formation, triggered by S1P receptor 2 signaling, accelerates inflammation and maintains disease progression in the early stages of NASH (118), as well as playing a crucial role in the transition from NASH to HCC and HCC metastases in later stages (36). The gene discussed is S1PR2; the disease is metabolic dysfunction-associated steatohepatitis.